Earnings
IRWD
12.35
+2.24%
0.27
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
362.56M
--
--
122.35M
--
--
0.00
--
--
--
9.19M
1.74M
495.84M
25.50M
23.40M
--
--
785.00K
--
--
14.49M
63.40M
559.24M
--
661.00K
0.00
--
--
--
--
--
31.51M
--
--
--
--
32.17M
430.26M
--
--
--
34.17M
464.43M
496.60M
161.00K
1.53B
-1.47B
--
--
--
62.64M
62.64M
559.24M
FY 2019-12-31
177.02M
--
--
117.25M
--
--
0.00
--
648.00K
--
10.69M
1.25M
306.85M
30.17M
32.60M
--
--
785.00K
--
--
32.34M
95.90M
402.75M
--
5.49M
0.00
--
--
--
--
--
34.57M
--
--
--
875.00K
40.93M
407.99M
--
--
--
47.08M
455.07M
496.00M
158.00K
1.48B
-1.57B
--
--
--
-93.25M
-93.25M
402.75M
FY 2018-12-31
173.17M
0.00
--
80.95M
--
--
0.00
--
0.00
--
11.06M
1.25M
266.44M
17.27M
--
--
--
785.00K
0.00
--
47.56M
65.61M
332.05M
--
18.12M
0.00
--
--
--
71.59M
--
53.47M
--
--
--
303.00K
119.52M
366.30M
--
--
--
42.60M
408.90M
528.42M
154.00K
1.39B
-1.59B
--
--
--
-196.37M
-196.37M
332.05M
FY 2017-12-31
125.74M
95.68M
--
82.16M
--
--
0.00
--
735.00K
--
7.29M
--
311.60M
17.27M
--
--
--
785.00K
159.91M
--
116.11M
294.08M
605.67M
--
15.96M
0.00
--
--
--
61.51M
--
45.55M
--
--
--
442.00K
66.03M
396.09M
--
--
--
133.71M
529.80M
595.83M
151.00K
1.32B
-1.31B
--
--
--
9.85M
9.85M
605.67M
FY 2016-12-31
54.00M
251.21M
--
64.85M
--
--
0.00
--
1.08M
--
9.03M
--
380.18M
20.51M
--
--
--
785.00K
166.12M
--
142.22M
329.64M
709.82M
--
17.70M
0.00
--
--
--
--
--
45.24M
--
--
--
21.96M
91.13M
366.57M
--
--
--
185.40M
551.97M
643.11M
148.00K
1.26B
-1.19B
--
--
--
66.72M
66.72M
709.82M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out IRWD latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Ironwood Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.